The role of steroid hormones in the protection against oxidative stress;A szteroidhormonok szerepe az oxidatív stressz elleni védekezésben

Lege Artis Medicinae

Volumn 11, Issue 2, 2001, Pages 100-106

  Bekesi G ^a   Feher J ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Antioxidant effect; Hormone replacement therapy; Myeloperoxidase enzyme; Steroid hormones; Superoxide anion; Vasoprotection

Indexed keywords

FREE RADICAL; MYELOPEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STEROID HORMONE; SUPEROXIDE;

AGING; ANTIOXIDANT ACTIVITY; ATHEROGENESIS; HORMONE SUBSTITUTION; NEUTROPHIL; OXIDATIVE STRESS; POSTMENOPAUSE; REVIEW; VASCULAR DISEASE;

EID: 0035069285     PISSN: 08664811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. The biology of estrogen-mediated repair of cardiovascular injury
2. Menopause and risk factors for coronary heart disease
3. Szív-érrendszeri veszélyeztetettség nok körében a nemi hormontermelés megszunte után
4. Postmenopausal hormone replacement therapy and cardiovascular mortality in Central Europe
5. Leukocyte activation in atherosclerosis, correlation with risk factors
6. Can free radicals induce coronary vasospasm and acute myocardial infarction?
7. Neutrophils obtained from obliterative atherosclerotic patients exhibit enhanced resting respiratory burst and increased degranulation in response to various stimuli
8. Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells
9. Corticosteroid (methylprednisolone) modulation of photoperoxidation by ultraviolet light in liposomes
10. Hormonpótlás-keringo alakelemek-reológiai tényezok
11. Emberi neutrophil granulocyták mieloperoxidáz aktivitásának és a belolük felszabaduló enzim mennyiségének változása ösztrogén hatására
12. Liposome oxidation and erythrocyte lysis by enzymically generated superoxide and hydrogen peroxide
13. Stereoisomer-specific inhibition of superoxide anion-induced rat aortic smooth muscle cell proliferation by 17 beta-estradiol is estrogen receptor dependent
14. Interactions of peroxynitrite with human plasma and its constituents: Oxidative damage and antioxidant depletion
15. Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts
16. Antioxidant protection of LDL by physiological concentrations of 17 beta estradiol. Requirement for estradiol modification
17. Dietary phytoestrogens
18. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein
19. Estrogen replacement therapy and lipoprotein (a)
20. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production
21. Female hormones reduce neutrophil responsiveness in vitro
22. Estrogen surge: A regulatory switch for superoxide radical generation at implantation
23. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters
24. Effect of hydrocortisone on superoxide radical production by phagocytosing spleen cells
25. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon
26. Human sperm capacitation induced by biological fluids and progesterone, but not by NADH or NADPH, is associated with the production of superoxide anion
27. Progesterone inhibits superoxide radical production by mononuclear phagocytes in pseudopregnant rats
28. Effect of estrogen (17 beta-estradiol) on the susceptibility of mice to disseminated gonococcal infection
29. In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus
30. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming
31. In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes
32. Effect of sex steroids on superoxide production by human granulocytes
33. Review of progress in sterol oxidations
34. Further studies on free-radical pathology in the major central nervous system disorders: Effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury
35. Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue
36. Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma
37. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation
38. Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation
39. A new 21-aminosteroid antioxidant lacking glucocorticoid activity stimulates adrenocorticotropin secretion and blocks arachidonic acid release from mouse pituitary tumor (AIT-20) cells
40. The 21-aminosteroid inhibitors of lipid peroxidation: Reactions with lipid peroxyl and phenoxy radicals
41. Dehydroepiandrosterone and a beta-agonist, energy transducers, alter antioxidant enzyme systems: Influence of chronic training and acute exercise in rats
42. Dehydroepiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride
43. Vascular effects of ovarian hormones
44. The changes in the myeloperoxidase activity of human neutrophil granulocytes and in the amount of enzyme deriving from them under the effect of oestrogen
45. Menopause and HRT: Effects on granulocyte myeloperoxidase activity, release and related free radical generation
46. Age and plasma myeloperoxidase concentration-relation to superoxide anion production
47. Termination of the respiratory burst in human neutrophils
48. Identification of transcriptional cis-element in introns 7 and 9 of the myeloperoxidase gene
49. Oestrogen-induced enhancement of myeloperoxidase activity in human polymorphonuclear leukocytes-a possible cause of oxidative stress in inflammatory cells
50. Changes in human plasma concentration and intracellular activity of myeloperoxidase in groups of different age and gender, relation to superoxide anion production
51. Changes in salivary peroxidase and polymorphonuclear neutrophil leukocyte enzyme activities during the menstrual cycle
52. Myeloperoxidase activity and nuclear segmentation of maternal neutrophils during normal pregnancy
53. The role of neutrophil activation and inflammatory mediators in the pathomechanism of acute pancreatitis
54. Active oxygen species and the functions of phagocytic leukocytes
55. Oxygen metabolism and the Toxic Properties of Phagocytes
56. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells
57. Inhibition of LDL oxidation and myeloperoxidase dependent tyrosyl radical formation by selective estrogen receptor modulator raloxifene (LY139481HCL)
58. Paradoxical actions of anti-oxidants in the oxidation of low density lipoprotein by peroxidases
59. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein
60. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide production
61. Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen
62. Effect of estrogen (17 beta estradiol) on the susceptibility of mice to disseminated gonococcal infection
63. Ambulatory - Not office - Blood pressures decline during hormone replacement therapy in healthy postmenopausal women
64. Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension
65. Effect of hormone replacement therapy on non-invasive cardiovascular haemodynamics
66. Influence of age and postmenopausal estrogen replacement therapy on carotid arterial stiffness in women
67. Az ösztrogénhiány és a hormonpótló kezelés hatȧsai patkány kis artériáinak biomechanikai tulajdonságaira
68. Medroxyprogesteron monoterápia és kombinált hormonpótló kezelés hatásai kis artériák biomechanikai tulajdonságaira
69. Direct relaxing effect of estradiol-17 beta and progesterone on rat saphenous artery
70. Menopauza-hypertonia-hormonpótlás: Kis veroerek biomechanikai változásainak, állatkísėrletes vizsgálata
71. The relationship between white blood cells and arterial disease